| Through new drug launches, panel discussions, and similar forums. | Patientadvokatur
> Lægemidler og relaterede behandlinger | Regulatorisk partnerskab
> Arbejde med regulerende myndigheder | 1.000 | Regional | Sometimes | 115028447628 |
| Regular roundtables and forums are being held with the Ministry of Health and Welfare, the NHIS [국민건강보험공단 – National Health Insurance Service], HIRA [건강보험심사평가원 – Health Insurance Review and Assessment Service], the Korea Medical Research Institute, and other relevant bodies, with a view to improving the pharmaceutical pricing system. | Kræft
> Kræft: de fleste typer | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 10.000 | National | Regularly | 114998266569 |
| We assess cost-effectiveness. | Lever
> Leversygdomme: de fleste typer | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 100.000 | National | Sometimes | 114998327089 |
| We nominate patient group representatives as committee members on bodies such as the HIPDC [Health Insurance Policy Deliberation Committee - 건강보험정책심의위원회] and the DREC [Drug Benefit Evaluation Committee -약제급여평가위원], and we play a role in gathering and conveying the views of patients to these bodies. | Generelt helbred
> Levering af sundhedsydelser | Regulatorisk partnerskab
> Deltag i Health Technology Assessment (HTA) og refusionsgennemgange | 100.000 | National | Regularly | 115009387424 |
| Regular roundtables and forums are being held with the Ministry of Health and Welfare, the NHIS [국민건강보험공단 – National Health Insurance Service], HIRA [건강보험심사평가원 – Health Insurance Review and Assessment Service], the Korea Medical Research Institute, and other relevant bodies, with a view to improving the pharmaceutical pricing system. | Kræft
> Kræft: de fleste typer | Regulatorisk partnerskab
> Deltag i/faciliter møder med politiske beslutningstagere/regulatorer | 10.000 | National | Regularly | 114998266569 |
| Attendance at relevant committee meetings and informal consultative sessions. | Medfødt
> Medfødt: hjerte | Regulatorisk partnerskab
> Deltag i/faciliter møder med politiske beslutningstagere/regulatorer | 10.000 | National | Rarely | 115003445044 |
| Activities include policy forums, stakeholder consultations, meetings with relevant government ministries, and related engagements. | Sjælden
> Sjældne sygdomme: de fleste typer | Regulatorisk partnerskab
> Deltag i/faciliter møder med politiske beslutningstagere/regulatorer | 1.000 | National | Regularly | 115033450975 |
| Convening public hearings in the National Assembly and submitting formal recommendations to the Ministry of Health and Welfare [in Korea]. | Mental sundhed
> Psykisk helbred: de fleste tilstande | Indflydelse på politik og lovgivning
> Påvirk sundhedspolitik og lovgivning | 5.000 | Regional | Sometimes | 115019561629 |
| Activities included participation in policy forums advocating for the reimbursement of treatments currently excluded from public health insurance coverage, including Durvalumab and the graft-versus-host disease treatment Belumosudil. | Kræft
> Kræft: blod | Indflydelse på politik og lovgivning
> Deltag i offentlige høringer og konsultationer | 100.000 | Regional | Sometimes | 115008918207 |
| Convening of National Assembly public hearings. | Mental sundhed
> Psykisk helbred: de fleste tilstande | Indflydelse på politik og lovgivning
> Deltag i offentlige høringer og konsultationer | 5.000 | Regional | Sometimes | 115019561629 |
| We engage in these activities [involvement with drug-pricing regulators] when seeking reimbursement coverage for new medicines, as well as at forums and panel discussions. | Kræft
> Kræft: blod | Indflydelse på politik og lovgivning
> Deltag i offentlige høringer og konsultationer | 1.000 | Regional | Sometimes | 115028455157 |
| Activities include participation in forums and debates, submission of petitions to the 인권위 [국가인권위원회 – National Human Rights Commission]. | Patientadvokatur
> Patientrettigheder | Indflydelse på politik og lovgivning
> Deltag i offentlige høringer og konsultationer | 5.000 | Regional | Regularly | 115033350867 |
| Participated in a National Assembly policy forum on medicines not covered by public health insurance to convey the patient perspective. | Kræft
> Kræft: bryst | Indflydelse på politik og lovgivning
> Deltag i offentlige høringer og konsultationer | 5.000 | National | Sometimes | 115058944486 |
| A request for the re-listing of a Parkinson's disease treatment. | Neurodegenerativ
> Parkinsons | Indflydelse på politik og lovgivning
> Håndtering af barrierer/anomalier i medicinsk behandling | 5.000 | National | Rarely | 115055431165 |
| Regular roundtables and forums are being held with the Ministry of Health and Welfare, the NHIS [국민건강보험공단 – National Health Insurance Service], HIRA [건강보험심사평가원 – Health Insurance Review and Assessment Service], the Korea Medical Research Institute, and other relevant bodies, with a view to improving the pharmaceutical pricing system. | Kræft
> Kræft: de fleste typer | Prisfastsættelse og overkommelighed
> Fortaler for retfærdig medicinprissætning | 10.000 | National | Regularly | 114998266569 |
| Participated in a National Assembly policy debate on non-reimbursable drugs to convey patients' voices, and engaged in a petition drive to advocate for reimbursement coverage. | Kræft
> Kræft: bryst | Prisfastsættelse og overkommelighed
> Fortaler for retfærdig medicinprissætning | 5.000 | National | Sometimes | 115058944486 |
| We assess cost-effectiveness. | Lever
> Leversygdomme: de fleste typer | Prisfastsættelse og overkommelighed
> Deltag i forhandlinger med prisrevisionsnævnet | 100.000 | National | Sometimes | 114998327089 |
| We engage in these activities [involvement with drug-pricing regulators] when seeking reimbursement coverage for new medicines, as well as at forums and panel discussions. | Kræft
> Kræft: blod | Prisfastsættelse og overkommelighed
> Deltag i forhandlinger med prisrevisionsnævnet | 1.000 | Regional | Sometimes | 115028455157 |
| Reimbursement rates for basic welfare recipients. | Mental sundhed
> Psykisk helbred: de fleste tilstande | Prisfastsættelse og overkommelighed
> Adresser omkostningsbarrierer for lavindkomst- og sårbare personer | 5.000 | Regional | Sometimes | 115021952415 |
| Inclusion of medical devices — such as continuous glucose monitors and insulin pumps — on the national health insurance formulary. | Endokrin
> Diabetes: type 1 | Prisfastsættelse og overkommelighed
> Fortalelse af optagelse af produktet på refusionslister/nationale formularer | 100.000 | National | No | 114998267322 |
| Activities included participation in policy forums advocating for the reimbursement of treatments currently excluded from public health insurance coverage, including Durvalumab [help the body's immune system recognize and destroy cancer] and the graft-versus-host disease treatment Belumosudil. | Kræft
> Kræft: blod | Prisfastsættelse og overkommelighed
> Fortalelse af optagelse af produktet på refusionslister/nationale formularer | 100.000 | Regional | Sometimes | 115008918207 |
| We engage in these activities [involvement with drug-pricing regulators] when seeking reimbursement coverage for new medicines, as well as at forums and panel discussions. | Kræft
> Kræft: blod | Prisfastsættelse og overkommelighed
> Fortalelse af optagelse af produktet på refusionslister/nationale formularer | 1.000 | Regional | Sometimes | 115028455157 |
| Participated in a National Assembly policy debate on non-reimbursable drugs to convey patients' voices, and engaged in a petition drive to advocate for reimbursement coverage. | Kræft
> Kræft: bryst | Prisfastsættelse og overkommelighed
> Fortalelse af optagelse af produktet på refusionslister/nationale formularer | 5.000 | National | Sometimes | 115058944486 |
| A request for the re-listing of a Parkinson's disease treatment. | Neurodegenerativ
> Parkinsons | Forbedring af adgangsveje
> Fremme retfærdig adgang til medicin/sundhedspleje | 5.000 | National | Rarely | 115055431165 |
| We nominate patient group representatives as committee members on bodies such as the HIPDC [Health Insurance Policy Deliberation Committee - 건강보험정책심의위원회] and the DREC [Drug Benefit Evaluation Committee -약제급여평가위원], and we play a role in gathering and conveying the views of patients to these bodies. | Generelt helbred
> Levering af sundhedsydelser | Evidensbaseret patientinput
> Brug patientindsigt til at informere beslutninger | 100.000 | National | Regularly | 115009387424 |
| We submit written recommendations on a regular basis. | Kræft
> Kræft: blod | Evidensbaseret patientinput
> Brug patientindsigt til at informere beslutninger | 10.000 | National | Regularly | 115056090120 |
| Participated in a National Assembly policy forum on medicines not covered by public health insurance to convey the patient perspective. | Kræft
> Kræft: bryst | Evidensbaseret patientinput
> Brug patientindsigt til at informere beslutninger | 5.000 | National | Sometimes | 115058944486 |
| We submit written recommendations on a regular basis. | Kræft
> Kræft: blod | Evidensbaseret patientinput
> Omsæt evidens og indsigter til politisk input | 10.000 | National | Regularly | 115056090120 |
| Attendance at relevant committee meetings and informal consultative sessions. | Medfødt
> Medfødt: hjerte | Institutionel styring
> Sikre repræsentation i statslige rådgivende organer | 10.000 | National | Rarely | 115003445044 |
| We nominate patient group representatives as committee members on bodies such as the HIPDC [Health Insurance Policy Deliberation Committee - 건강보험정책심의위원회] and the DREC [Drug Benefit Evaluation Committee -약제급여평가위원], and we play a role in gathering and conveying the views of patients to these bodies. | Generelt helbred
> Levering af sundhedsydelser | Institutionel styring
> Sikre repræsentation i statslige rådgivende organer | 100.000 | National | Regularly | 115009387424 |
| Activities include participation in forums and debates, submission of petitions to the 인권위 [국가인권위원회 – National Human Rights Commission]. | Patientadvokatur
> Patientrettigheder | Opretholdelse af patientrettigheder/forbedring af livskvalitet
> Beskyttelse/forbedring af patientoplevelsen | 5.000 | Regional | Regularly | 115033350867 |
interaktioner
handlinger & fortalervirksomhed
7 omtaler
